SCHEMBL932827

SCHEMBL932827

CC1=NC(c2ccncc2)(c2cccc(Br)c2)N=C1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 10/20 0.44
KCNH2 Q12809 1/20 0.35
CHRNA1 P02708 1/20 0.33
CHRNG P07510 1/20 0.33
CHRNB1 P11230 1/20 0.33
CHRNB2 P17787 1/20 0.33
SLC6A2 P23975 1/20 0.33
CHRNB4 P30926 1/20 0.33
SLC6A4 P31645 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA4 P43681 1/20 0.33
SLC6A3 Q01959 1/20 0.33
CHRND Q07001 1/20 0.33
MAPK1 P28482 2/20 0.33
ALDH1A1 P00352 1/20 0.33
KDR P35968 1/20 0.32
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
MAPT P10636 1/20 0.31
HCAR3 P49019 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL932806 0.90 BACE1 (0.41) BACE1KCNH2CHRNA1CHRNGCHRNB1
SCHEMBL932108 0.83 BACE1 (0.62) BACE1KCNH2BACE2CTSD
SCHEMBL931186 0.75 CHRNA1 (0.40) BACE1KCNH2CHRNA1CHRNGCHRNB1
SCHEMBL932046 0.72 BACE1 (0.60) BACE1KCNH2BACE2CTSD
SCHEMBL932151 0.72 CHRNA1 (0.35) BACE1CHRNA1CHRNGCHRNB1CHRNB2
SCHEMBL933512 0.69 BACE1 (0.63) BACE1KCNH2BACE2CTSD
SCHEMBL932706 0.67 BACE1 (0.66) BACE1KCNH2BACE2CTSD
SCHEMBL932111 0.67 BACE1 (0.47) BACE1KCNH2ALDH1A1NPC1RAB9A
SCHEMBL932757 0.64 BACE1 (0.44) BACE1KCNH2ALDH1A1RAB9AMAPT
SCHEMBL932844 0.64 BACE1 (0.50) BACE1KCNH2BACE2CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002407-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed
WO-2011002407-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed